Immunoprecise Antibodies Net Income
| IPADelisted Stock | USD 2.07 0.07 3.50% |
As of the 26th of February, Immunoprecise Antibodies retains the Market Risk Adjusted Performance of 1.35, downside deviation of 7.04, and Risk Adjusted Performance of 0.1812. Immunoprecise Antibodies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immunoprecise Antibodies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Immunoprecise Antibodies' valuation are provided below:Immunoprecise Antibodies does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Immunoprecise |
Search Suggestions
| I | Intelsat SA | CompanyDelisted |
| IE | Ivanhoe Electric | Company |
| IMPPP | Imperial Petroleum Preferred | Company |
| IAE | Voya Asia Pacific | Fund |
| IG | Principal Exchange Traded Funds | ETF |
| IRX | CBOE 13 Week | Index |
| ID | SPACE | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Immunoprecise Antibodies reported net income of (30.23 Million). This is 108.86% lower than that of the Biotechnology sector and 143.16% lower than that of the Health Care industry. The net income for all United States stocks is 105.3% higher than that of the company.
Immunoprecise Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immunoprecise Antibodies' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immunoprecise Antibodies could also be used in its relative valuation, which is a method of valuing Immunoprecise Antibodies by comparing valuation metrics of similar companies.Immunoprecise Antibodies is currently under evaluation in net income category among its peers.
Immunoprecise Fundamentals
| Return On Equity | -1.02 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | (1.23) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 98.45 M | |||
| Shares Outstanding | 46.15 M | |||
| Shares Owned By Insiders | 9.06 % | |||
| Shares Owned By Institutions | 8.66 % | |||
| Number Of Shares Shorted | 433.66 K | |||
| Price To Book | 5.61 X | |||
| Price To Sales | 3.90 X | |||
| Revenue | 24.52 M | |||
| Gross Profit | 13.55 M | |||
| EBITDA | (28.86 M) | |||
| Net Income | (30.23 M) | |||
| Cash And Equivalents | 19.24 M | |||
| Cash Per Share | 0.77 X | |||
| Total Debt | 13.4 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 5.06 X | |||
| Book Value Per Share | 0.51 X | |||
| Cash Flow From Operations | (6.41 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.66) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 81 | |||
| Beta | 0.55 | |||
| Market Capitalization | 95.54 M | |||
| Total Asset | 44.44 M | |||
| Retained Earnings | (128.79 M) | |||
| Working Capital | 9.74 M | |||
| Net Asset | 44.44 M |
About Immunoprecise Antibodies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immunoprecise Antibodies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunoprecise Antibodies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunoprecise Antibodies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Immunoprecise Stock
If you are still planning to invest in Immunoprecise Antibodies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immunoprecise Antibodies' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |